Highbridge Capital Management LLC Has $1.60 Million Position in CVS Health Corp (CVS)

Highbridge Capital Management LLC boosted its position in CVS Health Corp (NYSE:CVS) by 122.0% during the first quarter, Holdings Channel reports. The institutional investor owned 25,715 shares of the pharmacy operator’s stock after buying an additional 142,427 shares during the period. Highbridge Capital Management LLC’s holdings in CVS Health were worth $1,600,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also recently bought and sold shares of the company. Sentinel Trust Co. LBA boosted its position in shares of CVS Health by 430.9% during the 1st quarter. Sentinel Trust Co. LBA now owns 142,905 shares of the pharmacy operator’s stock worth $8,890,000 after purchasing an additional 115,985 shares in the last quarter. SPF Beheer BV boosted its position in shares of CVS Health by 31.4% during the 1st quarter. SPF Beheer BV now owns 1,074,744 shares of the pharmacy operator’s stock worth $66,860,000 after purchasing an additional 256,956 shares in the last quarter. Millennium Management LLC boosted its position in shares of CVS Health by 148.7% during the 1st quarter. Millennium Management LLC now owns 2,645,081 shares of the pharmacy operator’s stock worth $164,550,000 after purchasing an additional 1,581,570 shares in the last quarter. Highlander Capital Management LLC boosted its position in shares of CVS Health by 65.9% during the 1st quarter. Highlander Capital Management LLC now owns 3,400 shares of the pharmacy operator’s stock worth $207,000 after purchasing an additional 1,350 shares in the last quarter. Finally, Kiwi Wealth Investments Limited Partnership boosted its position in shares of CVS Health by 14.1% during the 1st quarter. Kiwi Wealth Investments Limited Partnership now owns 72,376 shares of the pharmacy operator’s stock worth $4,503,000 after purchasing an additional 8,966 shares in the last quarter. Hedge funds and other institutional investors own 83.18% of the company’s stock.

NYSE CVS opened at $71.43 on Tuesday. CVS Health Corp has a 12 month low of $60.14 and a 12 month high of $84.00. The company has a debt-to-equity ratio of 1.59, a current ratio of 2.37 and a quick ratio of 1.88. The stock has a market cap of $73.38 billion, a PE ratio of 12.11, a P/E/G ratio of 1.00 and a beta of 1.00.

CVS Health (NYSE:CVS) last posted its quarterly earnings data on Wednesday, May 2nd. The pharmacy operator reported $1.48 EPS for the quarter, beating the Zacks’ consensus estimate of $1.39 by $0.09. CVS Health had a net margin of 3.59% and a return on equity of 17.45%. The company had revenue of $45.69 billion during the quarter, compared to the consensus estimate of $45.77 billion. During the same quarter in the prior year, the company posted $1.17 EPS. The company’s quarterly revenue was up 2.6% compared to the same quarter last year. analysts expect that CVS Health Corp will post 6.98 earnings per share for the current fiscal year.

In other news, Director C David Brown II bought 10,000 shares of the firm’s stock in a transaction dated Friday, May 4th. The stock was acquired at an average price of $61.99 per share, for a total transaction of $619,900.00. Following the acquisition, the director now owns 101,252 shares of the company’s stock, valued at $6,276,611.48. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. 0.53% of the stock is currently owned by insiders.

Several equities research analysts have commented on CVS shares. Mizuho set a $95.00 target price on shares of CVS Health and gave the stock a “buy” rating in a research report on Wednesday, June 13th. Bank of America decreased their target price on shares of CVS Health from $91.00 to $88.00 and set a “buy” rating on the stock in a research report on Wednesday, April 11th. Leerink Swann set a $85.00 target price on shares of CVS Health and gave the stock a “buy” rating in a research report on Tuesday, April 10th. Loop Capital set a $68.00 target price on shares of CVS Health and gave the stock a “hold” rating in a research report on Monday, May 7th. Finally, ValuEngine lowered shares of CVS Health from a “hold” rating to a “sell” rating in a research report on Wednesday, May 2nd. Three analysts have rated the stock with a sell rating, six have assigned a hold rating, eleven have issued a buy rating and two have given a strong buy rating to the stock. The stock currently has an average rating of “Buy” and a consensus price target of $86.27.

CVS Health Company Profile

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order, specialty pharmacy and infusion services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply